Cover Image
市場調查報告書

拋棄式生物反應器的全球市場 至2021年的預測:各產品 (幹細胞、干擾素)、細胞、技術、用途、終端用戶

Single-use Bioreactor Market by Product (Stem cells, Interferons), Cell (Yeast, Plant cells), Technology (Bubble column bioreactors), Application (R&D, Bioproduction), End User (R&D department, Biopharmaceutical manufacturers) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 318616
出版日期 內容資訊 英文 151 Pages
訂單完成後即時交付
價格
Back to Top
拋棄式生物反應器的全球市場 至2021年的預測:各產品 (幹細胞、干擾素)、細胞、技術、用途、終端用戶 Single-use Bioreactor Market by Product (Stem cells, Interferons), Cell (Yeast, Plant cells), Technology (Bubble column bioreactors), Application (R&D, Bioproduction), End User (R&D department, Biopharmaceutical manufacturers) - Global Forecast to 2021
出版日期: 2016年10月04日 內容資訊: 英文 151 Pages
簡介

全球拋棄式生物反應器的市場規模,預計從2016年的4億840萬美元的規模,以21.6%年複合成長率(CAGR) 成長,2021年達到10億8570萬美元。促進這個市場成長的主要原因,是小企業、新設企業的投資報酬率 (ROI) 改善效果,及自動化中複雜化的迴避,對環境的正面影響等。在各技術中,由於彈性高和前置作業時間短,波浪誘導運動生物反應器佔最大的市場佔有率。各地區中,歐洲成為全球最大的市場,另一方面今後的市場成長率是亞太地區最大。

本報告以全球拋棄式生物反應器 (SUB) 市場為研究主題,提供市場概要,市場發展促進、阻礙因素,市場上課題及機會,各產品、細胞、技術、用途、終端用戶、地區的市場現況與展望相關調查分析,競爭環境,主要企業簡介彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 高級見解

第5章 拋棄式生物反應器的全球市場:概要

  • 簡介
  • 市場動態
    • 市場發展推動因素
      • 在小規模企業、新興企業SUB的引進增加
      • 緩和自動化中的複雜度
      • 海洋生物 (藻類) 培養的簡單化
      • 減輕對環境的影響
    • 市場發展阻礙因素
      • 對拋棄式生物反應器的相關法規的擔憂
      • 濾出物及萃取物相關問題
    • 市場機會
      • 生技藥品
      • 生技藥品市場成長
      • 專利到期
    • 課題
      • 柔軟的生物反應器相關規定
      • 拋棄式感測器的功能提高需求

第6章 拋棄式生物反應器的全球市場:產業趨勢

  • 產業趨勢
  • 供應鏈分析
  • PESTEL分析 (政治、經濟、社會、技術性、環境、法律上的要素)

第7章 拋棄式生物反應器的全球市場:各產品類型

  • 簡介
  • 單株抗體 (MAb)
  • 疫苗
  • 基因改造蛋白質
  • 幹細胞
  • 轉基因細胞
  • 其他的產品

第8章 拋棄式生物反應器的全球市場:各細胞類型

  • 簡介
  • 哺乳類細胞
  • 細菌性細胞
  • 酵母細胞
  • 其他

第9章 拋棄式生物反應器的全球市場:各技術

  • 簡介
  • 波浪誘導運動拋棄式生物反應器
  • 攪拌槽拋棄式生物反應器
  • 拋棄式氣泡塔生物反應器
  • 其他技術

第10章 拋棄式生物反應器的全球市場:各用途

  • 簡介
  • 生物生產
  • 製程發展
  • 研究開發 (R&D)

第11章 拋棄式生物反應器的全球市場:各終端用戶

  • 簡介
  • 生物醫藥品廠商
  • 研究開發 (R&D) 部門

第12章 拋棄式生物反應器的全球市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 其他
  • 亞太地區
  • 其他的國家 (RoW)

第13章 競爭情形

  • 概要
  • 競爭情形與趨勢
    • 新產品發表
    • 收購
    • 產業合作
    • 其他動向

第14章 企業簡介

  • 簡介
  • SARTORIUS STEDIM BIOTECH S.A.
  • MERCK MILLIPORE
  • GE HEALTHCARE
  • DANAHER CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
  • PARKER HANNIFIN CORPORATION
  • APPLIKON BIOTECHNOLOGY
  • CELLEXUS LIMITED
  • CELLTAINER BIOTECH BV
  • PBS BIOTECH, INC.

第15章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2863

The global single-use bioreactors market is projected to reach USD 1,085.7 million by 2021 from USD 408.4 million in 2016, growing at a CAGR of 21.6% during the forecast period (2016-2021). In this report, the single-use bioreactors market is broadly segmented on the basis of product type, cell type, technology, application, end user, and region. Factors such as improved return on investment for small companies and startups, reduced complexity in automation, and positive impact on the environment are driving the growth of the single-use bioreactors market.

On the basis of cell type, the single-use bioreactors market is categorized into mammalian cells, bacteria, yeast, and other cells (insect and plant cells). In 2016, the monoclonal antibodies segment is expected to account for the largest share of the single-use bioreactors market. Factors such as reduced risk of contamination and easy implementation in bioproduction are driving the adoption of SUBs for the production of these molecules. Based on technology, the single-use bioreactors market is categorized into wave-induced motion SUBs, stirred SUBs, single-use bubble column bioreactors, and others technologies. The wave-induced motion SUBs segment is expected to account for the largest market share in 2016. Growth in this segment can be attributed to the advantages offered by this technology such as high flexibility and shorter lead times.

Europe is expected to account for the largest share of the single-use bioreactors market in 2016. Patent cliff of many biologics drugs in Europe and government support for pharmaceutical companies to launch new biologics therapies with superior efficacy are driving the growth of the single-use bioreactors market in this region. The APAC single-use bioreactors market is expected to register the highest CAGR of 23.4% in the next five years. The rapidly growing healthcare industry and increasing investments by major pharmaceutical companies in this region are contributing to the high growth of the APAC single-use bioreactors market during the forecast period.

Product launches was the most widely adopted growth strategy pursued by players in the single-use bioreactors market, to increase their shares and cater to the unmet needs. The major players operating in the single-use bioreactors market include Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), GE Healthcare (U.S.), Danaher Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the single-use bioreactors market. The report provides an analysis of the single-use bioreactors market, by product type, cell type, application, technology, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the single-use bioreactors market
  • Market Development: Comprehensive information about lucrative emerging markets. This report provides an analysis of the single-use bioreactors market across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global single-use bioreactors market
  • Competitive Assessment: In-depth assessment of market strategies, product portfolios, and manufacturing capabilities of the leading players in the global single-use bioreactors market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
      • 2.2.2.1. Key industry insights
  • 2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. SINGLE-USE BIOREACTORS: MARKET OVERVIEW
  • 4.2. GEOGRAPHICAL ANALYSIS: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE (2016)
  • 4.3. SINGLE-USE BIOREACTORS MARKET, BY END USER
  • 4.4. SINGLE-USE BIOREACTORS MARKET, BY TECHNOLOGY
  • 4.5. GEOGRAPHICAL SNAPSHOT OF THE SINGLE-USE BIOREACTORS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing adoption of SUBs among small companies and startups
      • 5.2.1.2. Reduced automation complexity
      • 5.2.1.3. Ease in cultivation of marine organisms (ALGAE)
      • 5.2.1.4. Reduced environmental impact
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Regulatory concerns related to SUBs
      • 5.2.2.2. Issues regarding leachables and extractables
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growing biologics market
      • 5.2.3.2. Patent expiry
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Limitations in flexible bioreactors
      • 5.2.4.2. Need for improved single-use sensors

6. INDUSTRY INSIGHTS

  • 6.1. INDUSTRY INSIGHTS
  • 6.2. SUPPLY CHAIN ANALYSIS
  • 6.3. PESTEL ANALYSIS
    • 6.3.1. POLITICAL FACTORS
    • 6.3.2. ECONOMIC FACTORS
    • 6.3.3. SOCIAL FACTORS
    • 6.3.4. TECHNOLOGICAL FACTORS
    • 6.3.5. ENVIRONMENTAL FACTORS
    • 6.3.6. LEGAL FACTORS

7. SINGLE-USE BIOREACTORS MARKET, BY PRODUCT TYPE

  • 7.1. INTRODUCTION
  • 7.2. MONOCLONAL ANTIBODIES (MABS)
  • 7.3. VACCINES
  • 7.4. RECOMBINANT PROTEINS
  • 7.5. STEM CELLS
  • 7.6. GENE-MODIFIED CELLS
  • 7.7. OTHER PRODUCTS

8. SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL

  • 8.1. INTRODUCTION
  • 8.2. MAMMALIAN CELLS
  • 8.3. BACTERIAL CELLS
  • 8.4. YEAST CELLS
  • 8.5. OTHER CELLS

9. SINGLE-USE BIOREACTORS MARKET, BY TECHNOLOGY

  • 9.1. INTRODUCTION
  • 9.2. WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS
  • 9.3. STIRRED SINGLE-USE BIOREACTORS
  • 9.4. SINGLE-USE BUBBLE COLUMN BIOREACTORS
  • 9.5. OTHER TECHNOLOGIES

10. SINGLE-USE BIOREACTORS MARKET, BY APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. BIOPRODUCTION
  • 10.3. PROCESS DEVELOPMENT
  • 10.4. RESEARCH & DEVELOPMENT

11. GLOBAL SINGLE-USE BIOREACTORS MARKET, BY END USER

  • 11.1. INTRODUCTION
  • 11.2. BIOPHARMACEUTICAL MANUFACTURERS
  • 11.3. R&D DEPARTMENTS

12. GLOBAL SINGLE-USE BIOREACTORS MARKET, BY REGION

  • 12.1. INTRODUCTION
  • 12.2. NORTH AMERICA
    • 12.2.1. U.S.
    • 12.2.2. CANADA
  • 12.3. EUROPE
    • 12.3.1. U.K.
    • 12.3.2. GERMANY
    • 12.3.3. REST OF EUROPE (ROE)
  • 12.4. ASIA-PACIFIC
  • 12.5. REST OF THE WORLD (ROW)

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. COMPETITIVE SITUATION AND TRENDS
    • 13.2.1. PRODUCT LAUNCHES
    • 13.2.2. ACQUISITIONS
    • 13.2.3. COLLABORATIONS
    • 13.2.4. OTHERS

14. COMPANY PROFILES (Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*

  • 14.1. INTRODUCTION
  • 14.2. SARTORIUS STEDIM BIOTECH S.A.
  • 14.3. MERCK MILLIPORE
  • 14.4. GE HEALTHCARE
  • 14.5. DANAHER CORPORATION
  • 14.6. THERMO FISHER SCIENTIFIC, INC.
  • 14.7. PARKER HANNIFIN CORPORATION
  • 14.8. APPLIKON BIOTECHNOLOGY
  • 14.9. CELLEXUS LIMITED
  • 14.10. CELLTAINER BIOTECH BV
  • 14.11. PBS BIOTECH, INC.

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

15. APPENDIX

  • 15.1. INSIGHTS OF INDUSTRY EXPERTS
  • 15.2. DISCUSSION GUIDE
  • 15.3. OTHER DEVELOPMENTS
  • 15.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.6. AVAILABLE CUSTOMIZATIONS
  • 15.7. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: TYPICAL EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS
  • TABLE 2: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 3: SINGLE-USE BIOREACTORS MARKET SIZE FOR MABS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR MABS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 5: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR MABS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 6: SINGLE-USE BIOREACTORS MARKET SIZE FOR VACCINES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR VACCINES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR VACCINES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: SINGLE-USE BIOREACTORS MARKET SIZE FOR RECOMBINANT PROTEINS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR RECOMBINANT PROTEINS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR RECOMBINANT PROTEINS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: SINGLE-USE BIOREACTORS MARKET SIZE FOR STEM CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR STEM CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR STEM CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: SINGLE-USE BIOREACTORS MARKET SIZE FOR GENE-MODIFIED CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR GENE-MODIFIED CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR GENE-MODIFIED CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER PRODUCTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER PRODUCTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER PRODUCTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR MAMMALIAN CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR MAMMALIAN CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR MAMMALIAN CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR BACTERIAL CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR BACTERIAL CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR BACTERIAL CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR YEAST CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR YEAST CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR YEAST CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER CELLS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR OTHER CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: EUROPE: WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: NORTH AMERICA: WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: GLOBAL STIRRED SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: EUROPE: STIRRED SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: STIRRED SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: GLOBAL SINGLE-USE BUBBLE COLUMN BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 42: EUROPE: SINGLE-USE BUBBLE COLUMN BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: SINGLE-USE BUBBLE COLUMN BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL OTHER SINGLE-USE BIOREACTOR TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE: OTHER SINGLE-USE BIOREACTOR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: OTHER SINGLE-USE BIOREACTOR TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 48: SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPRODUCTION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPRODUCTION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPRODUCTION, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: SINGLE-USE BIOREACTORS MARKET SIZE FOR PROCESS DEVELOPMENT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR PROCESS DEVELOPMENT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR PROCESS DEVELOPMENT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 54: SINGLE-USE BIOREACTORS MARKET SIZE FOR RESEARCH & DEVELOPMENT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 55: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 58: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPHARMACEUTICAL MANUFACTURERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 59: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR BIOPHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 61: GLOBAL SINGLE-USE BIOREACTORS MARKET SIZE FOR R&D DEPARTMENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 63: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE FOR R&D DEPARTMENTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: SINGLE-USE BIOREACTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 65: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 68: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 69: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 71: U.S.: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: U.S.: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 73: U.S.: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 74: U.S.: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 75: U.S.: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 76: CANADA: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: CANADA: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 78: CANADA: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 79: CANADA: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 80: CANADA: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 81: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 82: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 84: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 85: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 86: EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 87: U.K.: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: U.K.: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 89: U.K.: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 90: U.K.: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 91: U.K.: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 92: GERMANY: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: GERMANY: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 94: GERMANY: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 95: GERMANY: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 96: GERMANY: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 97: REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 99: REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 100: REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 101: REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 102: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 104: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 105: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 106: ASIA-PACIFIC: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 107: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION)
  • TABLE 109: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 110: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 111: ROW: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 112: PRODUCT LAUNCHES, 2013-2016
  • TABLE 113: ACQUISITIONS, 2013-2016
  • TABLE 114: COLLABORATIONS, 2013-2016
  • TABLE 115: OTHERS, 2013 TO 2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: SINGLE-USE BIOREACTOR MARKET: TOP DOWN APPROACH
  • FIGURE 3: SINGLE-USE BIOREACTOR MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: SINGLE-USE BIOREACTORS MARKET SIZE, BY PRODUCT TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 7: SINGLE-USE BIOREACTORS MARKET SIZE, BY CELL TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: SINGLE-USE BIOREACTORS MARKET SIZE, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: SINGLE-USE BIOREACTORS MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: SINGLE-USE BIOREACTORS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT: SINGLE-USE BIOREACTORS MARKET
  • FIGURE 12: RISING FOCUS ON REDUCING OPERATIONAL COSTS-A PRIMARY GROWTH DRIVER OF THE SINGLE-USE BIOREACTORS MARKET
  • FIGURE 13: MAMMALIAN CELLS TO ACCOUNT FOR THE LARGEST SHARE IN 2016
  • FIGURE 14: BIOPHARMACEUTICAL MANUFACTURERS WILL CONTINUE TO DOMINATE THE SINGLE-USE BIOREACTORS MARKET IN 2021
  • FIGURE 15: WAVE-INDUCED MOTION SINGLE-USE BIOREACTORS ARE PROJECTED TO BE THE FASTEST-GROWING TECHNOLOGY SEGMENT DURING FORECAST PERIOD
  • FIGURE 16: APAC WILL BE THE FASTEST-GROWING REGIONAL MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: GLOBAL SINGLE-USE BIOREACTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: U.S.: BIOLOGICS GOING OFF-PATENT IN THE COMING YEARS
  • FIGURE 19: SUPPLY CHAIN: SINGLE-USE BIOREACTORS MARKET
  • FIGURE 20: MONOCLONAL ANTIBODIES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOREACTORS MARKET IN 2016
  • FIGURE 21: U.K. TO BE THE FASTEST-GROWING SEGMENT OF THE SINGLE-USE BIOREACTORS MARKET FOR MABS
  • FIGURE 22: EUROPE TO ACCOUNT FOR THE LARGEST SHARE OF THE SINGLE-USE BIOREACTORS MARKET FOR RECOMBINANT PROTEINS IN 2016
  • FIGURE 23: U.S. TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET FOR GENE-MODIFIED CELLS IN 2016
  • FIGURE 24: ASIA-PACIFIC TO BE THE FASTEST GROWING SEGMENT OF SINGLE-USE BIOREACTORS MARKET FOR OTHER PRODUCTS DURING THE FORECAST PERIOD
  • FIGURE 25: GLOBAL SINGLE-USE BIOREACTORS MARKET, BY TYPE OF CELL (2016-2021)
  • FIGURE 26: EUROPE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE SUBS MARKET FOR BACTERIAL CELLS IN 2016
  • FIGURE 27: THE U.K. IS EXPECTED TO BE THE FASTEST-GROWING COUNTRY IN THE EUROPEAN SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS DURING THE FORECAST PERIOD
  • FIGURE 28: WAVE-INDUCED MOTION SUBS ARE PROJECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 29: EUROPE TO DOMINATE THE STIRRED SINGLE-USE BIOREACTORS TECHNOLOGY SEGMENT IN 2016
  • FIGURE 30: THE U.K. IS EXPECTED TO BE THE FASTEST-GROWING COUNTRY IN THE EUROPEAN SINGLE-USE BUBBLE COLUMN BIOREACTORS MARKET DURING THE FORECAST PERIOD
  • FIGURE 31: BIOPRODUCTION TO ACCOUNT FOR THE LARGEST MARKET SHARE DURING THE FORECAST PERIOD
  • FIGURE 32: U.S. TO DOMINATE THE NORTH AMERICAN MARKET FOR PROCESS DEVELOPMENT
  • FIGURE 33: EUROPE TO DOMINATE THE SINGLE-USE BIOREACTORS MARKET FOR R&D DURING THE FORECAST PERIOD
  • FIGURE 34: BIOPHARMACEUTICAL MANUFACTURERS FORM THE LARGEST END-USER SEGMENT OF THE SINGLE-USE BIOREACTORS MARKET
  • FIGURE 35: EUROPE TO DOMINATE THE SINGLE-USE BIOREACTORS MARKET FOR BIOPHARMACEUTICAL MANUFACTURERS DURING THE FORECAST PERIOD
  • FIGURE 36: GEOGRAPHIC SNAPSHOT: ASIA-PACIFIC IS PROJECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 37: MAMMALIAN CELLS SEGMENT WILL WITNESS HIGH GROWTH IN THE NORTH AMERICAN AND ASIA-PACIFIC MARKETS
  • FIGURE 38: NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SNAPSHOT
  • FIGURE 39: R&D SEGMENT TO GROW AT THE HIGHEST RATE IN THE NORTH AMERICAN SINGLE-USE BIOREACTORS APPLICATIONS MARKET
  • FIGURE 40: BIOPHARMACEUTICAL MANUFACTURERS SEGMENT TO DOMINATE THE U.S. SINGLE-USE BIOREACTORS MARKET, BY END USER
  • FIGURE 41: EUROPE: SINGLE-USE BIOREACTORS MARKET SNAPSHOT
  • FIGURE 42: MONOCLONAL ANTIBODIES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN SINGLE-USE BIOREACTORS MARKET, BY PRODUCT TYPE
  • FIGURE 43: WAVE-INDUCED MOTION SUB TO DOMINATE THE U.K. SINGLE-USE BIOREACTORS MARKET, BY TECHNOLOGY
  • FIGURE 44: R&D DEPARTMENTS TO WITNESS THE HIGHEST GROWTH IN THE SINGLE-USE BIOREACTORS END-USERS MARKET IN GERMANY
  • FIGURE 45: MONOCLONAL ANTIBODIES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC SINGLE-USE BIOREACTORS MARKET, BY PRODUCT TYPE
  • FIGURE 46: WAVE-INDUCED MOTION SUB TO DOMINATE THE ROW SINGLE-USE BIOREACTORS MARKET, BY APPLICATION
  • FIGURE 47: PRODUCT LAUNCHES WAS THE MOST WIDELY ADOPTED GROWTH STRATEGY BY MARKET PLAYERS BETWEEN 2013 & 2016
  • FIGURE 48: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES ACCOUNTED FOR THE LARGEST SHARE OF THE OVERALL GROWTH STRATEGIES ADOPTED BY PLAYERS BETWEEN 2013 & 2016
  • FIGURE 49: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
  • FIGURE 50: COMPANY SNAPSHOT: SARTORIUS STEDIM BIOTECH S.A.
  • FIGURE 51: COMPANY SNAPSHOT: MERCK MILLIPORE
  • FIGURE 52: COMPANY SNAPSHOT: GE HEALTHCARE
  • FIGURE 53: COMPANY SNAPSHOT: DANAHER CORPORATION
  • FIGURE 54: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
  • FIGURE 55: COMPANY SNAPSHOT: PARKER HANNIFIN CORPORATION
Back to Top